Unknown

Dataset Information

The burden of hyperkalemia in Germany - a real world evidence study assessing the treatment and costs of hyperkalemia.


ABSTRACT:

Background

Hyperkalemia (HK) can affect health outcomes and quality of life, as it is referred to as a potentially life-threatening condition caused by an increased serum potassium concentration in the blood. Patients suffering from heart failure or chronic kidney diseases are at a higher risk of HK, which can further be amplified by the treatment received. To date, data on HK prevalence is lacking for Germany and the aims of this study were to assess HK and compare health-relevant outcomes and healthcare costs between HK patients and non-HK patients.

Methods

The InGef research database containing healthcare claims of over 4 million individuals in Germany was utilized for this retrospective, matched cohort analysis. Patients with non-acute outpatient treated and a subgroup o

SUBMITTER: Haas JS 

PROVIDER: S-EPMC7414716 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature